Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (71-80 of 294) with videos related to

Pageof 30
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 4, 2023
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologistsMichael Oertel, Christian Berdel, Gerhard Held, et al.
Cancers|June 10, 2023
Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma-A Critical Toxicity Evaluation in the Modern Treatment EraMichael Oertel, Tom Schlusemann, Evgenii Shumilov, et al.
Annals of Hematology|August 24, 2020
Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemiaRamona Wullenkord, Christian Reicherts, Jan-Henrik Mikesch, et al.
Frontiers in Oncology|August 5, 2022
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple MyelomaSarah Sandmann, Katharina Karsch, Peter Bartel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2010
Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cellsBernhard Kloo, Daniel Nagel, Matthias Pfeifer, et al.
Cancers|November 27, 2021
The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell TransplantationMichael Oertel, Jonas Martel, Jan-Henrik Mikesch, et al.
Annals of Hematology|April 29, 2017
Successful second allogeneic stem cell transplantation in a patient with T-lymphoblastic leukemia (T-ALL) relapsed as myeloid sarcomaSvenja Matern, Eva Schmidt, David Hartmann, et al.
Transplantation and Cellular Therapy|April 28, 2021
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive TherapyWolfgang Roll, Georg Evers, Rebecca Strotmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditionsFlorian Scholz, Michael Grau, Lutz Menzel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2015
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activationNathalie Knies, Begüm Alankus, Andre Weilemann, et al.
Pageof 30

Showing results (71-80 of 294) with videos related to

Sort By:
Pageof 30
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 4, 2023
The new German evidence-based guideline on diffuse large B-cell lymphoma-key aspects for radiation oncologistsMichael Oertel, Christian Berdel, Gerhard Held, et al.
Cancers|June 10, 2023
Radiotherapy in Combination with Systemic Therapy for Multiple Myeloma-A Critical Toxicity Evaluation in the Modern Treatment EraMichael Oertel, Tom Schlusemann, Evgenii Shumilov, et al.
Annals of Hematology|August 24, 2020
Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemiaRamona Wullenkord, Christian Reicherts, Jan-Henrik Mikesch, et al.
Frontiers in Oncology|August 5, 2022
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple MyelomaSarah Sandmann, Katharina Karsch, Peter Bartel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2010
Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cellsBernhard Kloo, Daniel Nagel, Matthias Pfeifer, et al.
Cancers|November 27, 2021
The Burden of Survivorship on Hematological Patients-Long-Term Analysis of Toxicities after Total Body Irradiation and Allogeneic Stem Cell TransplantationMichael Oertel, Jonas Martel, Jan-Henrik Mikesch, et al.
Annals of Hematology|April 29, 2017
Successful second allogeneic stem cell transplantation in a patient with T-lymphoblastic leukemia (T-ALL) relapsed as myeloid sarcomaSvenja Matern, Eva Schmidt, David Hartmann, et al.
Transplantation and Cellular Therapy|April 28, 2021
Fluorodeoxyglucose F 18 for the Assessment of Acute Intestinal Graft-versus-Host Disease and Prediction of Response to Immunosuppressive TherapyWolfgang Roll, Georg Evers, Rebecca Strotmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 2020
The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditionsFlorian Scholz, Michael Grau, Lutz Menzel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 16, 2015
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activationNathalie Knies, Begüm Alankus, Andre Weilemann, et al.
Pageof 30